HPSC exosomes were enriched with the proteoglycan, glypican-1 (GPC1), which was suggested as a biomarker to detect PDAC (24); however, another study reported that exosomal GPC1 was unable to differentiate patients with pancreatic cancers from healthy controls (25). This evidence concerns the gene GPC1 and pancreatic neoplasm.